AbbVie to Acquire Pharmacyclics for $21 Billion

05.03.2015 - US drugmaker AbbVie has reached final agreement to acquire compatriot Pharmacyclics and the company's flagship asset Imbruvica (ibrutinib), which it describes as "a highly...